Current Opinion in Oncology

Papers
(The H4-Index of Current Opinion in Oncology is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Neoadjuvant immunotherapy in melanoma: pathological response as a surrogate endpoint?56
Is there still a place for lymph node dissection for stage III melanoma since the approval of adjuvant therapy39
Progress in diagnosis and treatment of checkpoint inhibitor pneumonitis33
Content features and its implementation in novel app-based psycho-oncological interventions for cancer survivors: a narrative review30
Treatments and challenges in advanced prostate cancer27
Collecting information from all sarcoma reference cancer centres worldwide: achievement and next steps26
Role of PSMA PET/CT in imaging and management of prostate cancer26
State of the art and upcoming trends in HER2-directed therapies in gastrointestinal malignancies24
Editorial introductions24
First and further-line multidisciplinary treatment of retroperitoneal sarcomas23
Epigenetic dynamics of aging and cancer development: current concepts from studies mapping aging and cancer epigenomes21
The role of signaling lymphocyte activation molecule family receptors in hematologic malignancies19
Harnessing dendritic cells for innovative therapeutic cancer vaccines17
Neurorehabilitation in brain tumours: evidences and suggestions for spreading of knowledge and research implementation17
Psycho-oncology interventions focusing on fatigue and sleep disturbances17
Can we yet use tertiary lymphoid structures as predictive biomarkers for immunotherapy response in melanoma?16
Editorial introductions16
Safety of assisted reproductive techniques in gynecological cancer patients16
New hopes in relapsed refractory primary central nervous system lymphoma16
Editorial introductions16
0.10440301895142